It was reported that an approximately 66 yo female patient, initial hip implanted, on (b)(6) 2014, underwent a revision procedure on (b)(6) 2024, approximately 9 years 2 months post the initial procedure.As part of the manufacturer's recall campaign, the patient presented herself for a check-up.In the x-ray control, there was a clear decentering of the prosthesis head and unusually large osteolysis in the acetabulum as a sign of inlay wear.The inlay was changed to a vitd-hardened one on (b)(6) 2024, specially approved inlay (novation xle, +5mm lateralized liner, group 1, 32 mm i.D., ref: (b)(4), sn: (b)(6).As part of the replacement operation, in addition to the inlay replacement, the firmness was determined cup integrity as well as the curettage and sealing of the cysts in the socket using allogeneic cancellous bone and changing the prosthetic head.Diagnosis that led to implantation: primary coxarthrosis m16.1 implanting clinic: bwkrhs westerstede.Item data of the implantation and replacement, as well as photos of the explants, will be sent upon confirmation of receipt with bfarm case number submitted later.The explants are currently in the laboratory doctor's office for microbiological examination using sonication.After graduation after the examination (14 days of long-term incubation), these are sent back to us and then once received, returning them to the manufacturer is subject to the patient's consent.Surgical reports/x-rays may also be available upon request.No further information.
|
H3: based on the available information, the patient involved meets the following risk criteria for early prosthesis wear/osteolysis as specified in the hhe: implanted with a lateralized liner.The most likely cause for the revision reported due to early prosthesis wear/osteolysis is a combination of the risk factors specified in the hhe.However, this cannot be confirmed from the reported information.
|